nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—Allergic cutaneous angiitis—Methotrexate—ankylosing spondylitis	0.0349	0.0349	CcSEcCtD
Nebivolol—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.0226	0.0226	CcSEcCtD
Nebivolol—Psoriasis—Methotrexate—ankylosing spondylitis	0.0176	0.0176	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.014	0.014	CcSEcCtD
Nebivolol—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Nebivolol—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Nebivolol—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.01	0.01	CcSEcCtD
Nebivolol—Bradycardia—Prednisolone—ankylosing spondylitis	0.00933	0.00933	CcSEcCtD
Nebivolol—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00926	0.00926	CcSEcCtD
Nebivolol—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00924	0.00924	CcSEcCtD
Nebivolol—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.0092	0.0092	CcSEcCtD
Nebivolol—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00918	0.00918	CcSEcCtD
Nebivolol—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00871	0.00871	CcSEcCtD
Nebivolol—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00858	0.00858	CcSEcCtD
Nebivolol—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00856	0.00856	CcSEcCtD
Nebivolol—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.0084	0.0084	CcSEcCtD
Nebivolol—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.0084	0.0084	CcSEcCtD
Nebivolol—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00835	0.00835	CcSEcCtD
Nebivolol—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00835	0.00835	CcSEcCtD
Nebivolol—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00781	0.00781	CcSEcCtD
Nebivolol—Bradycardia—Betamethasone—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Nebivolol—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Nebivolol—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00766	0.00766	CcSEcCtD
Nebivolol—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00737	0.00737	CcSEcCtD
Nebivolol—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00732	0.00732	CcSEcCtD
Nebivolol—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00731	0.00731	CcSEcCtD
Nebivolol—Angioedema—Prednisolone—ankylosing spondylitis	0.00729	0.00729	CcSEcCtD
Nebivolol—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00727	0.00727	CcSEcCtD
Nebivolol—Vertigo—Prednisolone—ankylosing spondylitis	0.00717	0.00717	CcSEcCtD
Nebivolol—Syncope—Prednisolone—ankylosing spondylitis	0.00716	0.00716	CcSEcCtD
Nebivolol—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00701	0.00701	CcSEcCtD
Nebivolol—Bradycardia—Prednisone—ankylosing spondylitis	0.00678	0.00678	CcSEcCtD
Nebivolol—Angioedema—Triamcinolone—ankylosing spondylitis	0.0067	0.0067	CcSEcCtD
Nebivolol—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00669	0.00669	CcSEcCtD
Nebivolol—Vertigo—Triamcinolone—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Nebivolol—Syncope—Triamcinolone—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Nebivolol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Nebivolol—Syncope—Methylprednisolone—ankylosing spondylitis	0.00657	0.00657	CcSEcCtD
Nebivolol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Nebivolol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Nebivolol—Shock—Prednisolone—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Nebivolol—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Nebivolol—Angioedema—Betamethasone—ankylosing spondylitis	0.00608	0.00608	CcSEcCtD
Nebivolol—Angioedema—Dexamethasone—ankylosing spondylitis	0.00608	0.00608	CcSEcCtD
Nebivolol—Vertigo—Betamethasone—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Nebivolol—Vertigo—Dexamethasone—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Nebivolol—Syncope—Dexamethasone—ankylosing spondylitis	0.00597	0.00597	CcSEcCtD
Nebivolol—Syncope—Betamethasone—ankylosing spondylitis	0.00597	0.00597	CcSEcCtD
Nebivolol—Shock—Triamcinolone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Nebivolol—Insomnia—Prednisolone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Nebivolol—Shock—Methylprednisolone—ankylosing spondylitis	0.00588	0.00588	CcSEcCtD
Nebivolol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Nebivolol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Nebivolol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Nebivolol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Nebivolol—Mental disorder—Prednisone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Nebivolol—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.0058	0.0058	CcSEcCtD
Nebivolol—Malnutrition—Prednisone—ankylosing spondylitis	0.0058	0.0058	CcSEcCtD
Nebivolol—Insomnia—Triamcinolone—ankylosing spondylitis	0.00542	0.00542	CcSEcCtD
Nebivolol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Nebivolol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Nebivolol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00537	0.00537	CcSEcCtD
Nebivolol—Shock—Betamethasone—ankylosing spondylitis	0.00535	0.00535	CcSEcCtD
Nebivolol—Shock—Dexamethasone—ankylosing spondylitis	0.00535	0.00535	CcSEcCtD
Nebivolol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Nebivolol—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Nebivolol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Nebivolol—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Nebivolol—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Nebivolol—Angioedema—Prednisone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Nebivolol—Vertigo—Prednisone—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Nebivolol—Syncope—Prednisone—ankylosing spondylitis	0.0052	0.0052	CcSEcCtD
Nebivolol—Urticaria—Prednisolone—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Nebivolol—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Nebivolol—Fatigue—Triamcinolone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Nebivolol—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00515	0.00515	CcSEcCtD
Nebivolol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.0051	0.0051	CcSEcCtD
Nebivolol—Insomnia—Dexamethasone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Nebivolol—Insomnia—Betamethasone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Nebivolol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Nebivolol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Nebivolol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Nebivolol—Mental disorder—Methotrexate—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Nebivolol—Malnutrition—Methotrexate—ankylosing spondylitis	0.00485	0.00485	CcSEcCtD
Nebivolol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0048	0.0048	CcSEcCtD
Nebivolol—Urticaria—Triamcinolone—ankylosing spondylitis	0.00476	0.00476	CcSEcCtD
Nebivolol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Nebivolol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00469	0.00469	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00469	0.00469	CcSEcCtD
Nebivolol—Fatigue—Betamethasone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Nebivolol—Fatigue—Dexamethasone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Nebivolol—Shock—Prednisone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Nebivolol—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Nebivolol—Skin disorder—Prednisone—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Nebivolol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Nebivolol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Nebivolol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Nebivolol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0044	0.0044	CcSEcCtD
Nebivolol—Vertigo—Methotrexate—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Nebivolol—Urticaria—Dexamethasone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Nebivolol—Urticaria—Betamethasone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Nebivolol—Dizziness—Prednisolone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Nebivolol—Asthenia—Triamcinolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Nebivolol—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Nebivolol—Abdominal pain—Betamethasone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Nebivolol—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Nebivolol—Insomnia—Prednisone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Nebivolol—Paraesthesia—Prednisone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Nebivolol—Pruritus—Triamcinolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Nebivolol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Nebivolol—Chest pain—Methotrexate—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Nebivolol—Rash—Prednisolone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Nebivolol—Dermatitis—Prednisolone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Nebivolol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Nebivolol—Fatigue—Prednisone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Nebivolol—Headache—Prednisolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Nebivolol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Nebivolol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Nebivolol—Asthenia—Betamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Nebivolol—Asthenia—Dexamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Nebivolol—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Nebivolol—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Nebivolol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Nebivolol—Nausea—Prednisolone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Nebivolol—Pruritus—Dexamethasone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Nebivolol—Pruritus—Betamethasone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Nebivolol—Skin disorder—Methotrexate—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Nebivolol—Vomiting—Triamcinolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Nebivolol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Nebivolol—Rash—Triamcinolone—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Nebivolol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Nebivolol—Rash—Methylprednisolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Nebivolol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Nebivolol—Urticaria—Prednisone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Nebivolol—Headache—Triamcinolone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Nebivolol—Headache—Methylprednisolone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Nebivolol—Abdominal pain—Prednisone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Nebivolol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Nebivolol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Nebivolol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Nebivolol—Dizziness—Betamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Nebivolol—Insomnia—Methotrexate—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Nebivolol—Nausea—Triamcinolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Nebivolol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Nebivolol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Nebivolol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Nebivolol—Somnolence—Methotrexate—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Nebivolol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Nebivolol—Vomiting—Dexamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Nebivolol—Vomiting—Betamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Nebivolol—Rash—Dexamethasone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Nebivolol—Rash—Betamethasone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Nebivolol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Nebivolol—Dermatitis—Betamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Nebivolol—Fatigue—Methotrexate—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Nebivolol—Headache—Betamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Nebivolol—Headache—Dexamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Nebivolol—Asthenia—Prednisone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Nebivolol—Pruritus—Prednisone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Nebivolol—Diarrhoea—Prednisone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Nebivolol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Nebivolol—Nausea—Dexamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Nebivolol—Nausea—Betamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Nebivolol—Urticaria—Methotrexate—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Nebivolol—Dizziness—Prednisone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nebivolol—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nebivolol—Vomiting—Prednisone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Nebivolol—Rash—Prednisone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Nebivolol—Dermatitis—Prednisone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Nebivolol—Headache—Prednisone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Nebivolol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Nebivolol—Asthenia—Methotrexate—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nebivolol—Nausea—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Nebivolol—Pruritus—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Nebivolol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Nebivolol—Dizziness—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Nebivolol—Vomiting—Methotrexate—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Nebivolol—Rash—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Nebivolol—Dermatitis—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Nebivolol—Headache—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nebivolol—Nausea—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
